References
- Bi X, Xia X, Mou T, Jiang B, Fan D, Wang P, Liu Y, Hou Y, Zhao Y. 2014. Anti-tumor activity of three ginsenoside derivatives in lung cancer is associated with Wnt/β-catenin signaling inhibition. Euro J Pharmacol. 742:145–152.
- Cragg GM, Grothaus PG, Newman DJ. 2009. Impact of natural products on developing new anti-cancer agents. Chem Rev. 109(7):3012–3043.
- HemaIswarya S, Doble M. 2006. Potential synergism of natural products in the treatment of cancer. Phytother Res. 20(4):239–249.
- Newman DJ, Cragg GM. 2016. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 79(3):629–661.
- Sagar S, Esau L, Moosa B, Khashab NM, Bajic VB, Kaur M. 2014. Cytotoxicity and apoptosis induced by a plumbagin derivative in estrogen positive MCF-7 breast cancer cells. Anticancer Agents Med Chem. 14(1):170–180.
- Shi L, Meng XJ, Cao JQ, Zhao YQ. 2012. A new triterpenoid saponin from Gynostemma pentaphyllum. Nat Prod Res. 26(15):1419–1422.
- Siegel R, Ma J, Zou Z, Jemal A. 2014. Cancer statistics. CA Cancer J Clin. 64(1):9–29.
- Stevens KN, Vachon CM, Couch FJ. 2013. Genetic susceptibility to triple-negative breast cancer. Cancer Res. 73(7):2025–2030.
- Wang K, Zhu X, Zhang K, Zhu L, Zhou FF. 2014. Investigation of gallic acid induced anticancer effect in human breast carcinoma MCF-7 cells. J Biochem Mol Toxicol. 28(9):387–393.
- Zhang XS, Cao JQ, Zhao C, Wang XD, Wu XJ, Zhao YQ. 2015. Novel dammarane-type triterpenes isolated from hydrolyzate of total Gynostemma pentaphyllum saponins. Bioorg Med Chem Lett. 25(16):3095–3099.
- Zhang XS, Shi GH, Liu MB, Chen R, Wu XJ, Zhao YQ. 2018. Four new dammarane-type triterpenes derivatives from hydrolyzate of total Gynostemma pentaphyllum saponins and their bioactivities. Nat. Prod. Res. 23:1–7.